We are live on ! Find out more
DJSG

D.J. St. Germain Portfolio holdings

AUM $2.78B
1-Year Est. Return 23.87%
This Fund
S&P 500
This Quarter Est. Return
+3.07%
1 Year Est. Return
+23.87%
3 Year Est. Return
+65.33%
5 Year Est. Return
10 Year Est. Return
AUM
$653M
AUM Growth
-$28.9M
Cap. Flow
-$46.4M
Cap. Flow %
-7.09%
Top 10 Hldgs %
32.66%
Holding
110
New
5
Increased
13
Reduced
75
Closed
3

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$2.99M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$927K
3
F icon
Ford
F
+$705K
4
T icon
AT&T
T
+$389K
5
FCX icon
Freeport-McMoran
FCX
+$311K

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Healthcare 13.06%
3 Energy 12.92%
4 Financials 11.32%
5 Industrials 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$184B
$12.4M 1.9%
148,705
-4,203
-3% -$341K
HAL icon
27
Halliburton
HAL
$27.3B
$12M 1.84%
204,605
-11,068
-5% -$591K
CCC
28
DELISTED
Calgon Carbon Corp
CCC
$11.4M 1.74%
521,179
-30,138
-5% -$616K
MBB icon
29
iShares MBS ETF
MBB
$38.9B
$11.3M 1.73%
106,626
-19,041
-15% -$2.02M
FCX icon
30
Freeport-McMoran
FCX
$91.3B
$10.7M 1.63%
322,783
+9,347
+3% +$311K
SCHW
31
Charles Schwab
SCHW
$177B
$10.5M 1.6%
383,384
-286,950
-43% -$7.5M
AXP icon
32
American Express
AXP
$233B
$10.3M 1.57%
114,076
-5,513
-5% -$492K
EXPD icon
33
Expeditors International
EXPD
$23B
$9.26M 1.42%
233,727
-14,393
-6% -$590K
TEVA icon
34
Teva Pharmaceuticals
TEVA
$36.3B
$8.05M 1.23%
152,438
-11,115
-7% -$514K
SPY icon
35
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$7.07M 1.08%
37,779
-1,785
-5% -$328K
VWO icon
36
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$6.59M 1.01%
162,513
+23,895
+17% +$927K
MDY icon
37
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$6.48M 0.99%
25,856
-1,685
-6% -$413K
WFC icon
38
Wells Fargo
WFC
$261B
$5.09M 0.78%
102,287
-7,642
-7% -$356K
HRL icon
39
Hormel Foods
HRL
$13.8B
$5.08M 0.78%
206,100
-9,300
-4% -$214K
VEA icon
40
Vanguard FTSE Developed Markets ETF
VEA
$226B
$4.79M 0.73%
115,999
-14,485
-11% -$593K
PBCT
41
DELISTED
People's United Financial Inc
PBCT
$3.52M 0.54%
236,820
-12,535
-5% -$182K
GLW icon
42
Corning
GLW
$134B
$3.24M 0.5%
155,630
-73,480
-32% -$1.38M
VB icon
43
Vanguard Small-Cap ETF
VB
$79.3B
$3.21M 0.49%
28,457
-1,498
-5% -$166K
BRCM
44
DELISTED
BROADCOM CORP CL-A
BRCM
$3.21M 0.49%
101,927
-8,928
-8% -$269K
TGT icon
45
Target
TGT
$61.1B
$3.05M 0.47%
+50,470
New +$2.99M
T icon
46
AT&T
T
$160B
$3.05M 0.47%
114,980
+15,508
+16% +$389K
DSL
47
DoubleLine Income Solutions Fund
DSL
$1.22B
$2.87M 0.44%
135,350
+1,960
+1% +$41.5K
PFE icon
48
Pfizer
PFE
$143B
$2.59M 0.4%
85,098
-7,747
-8% -$231K
NWBI icon
49
Northwest Bancshares
NWBI
$2.24B
$2.58M 0.4%
176,955
+295
+0.2% +$4.26K
EEM icon
50
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$2.48M 0.38%
60,512
-6,115
-9% -$240K

Similar funds

D.J. St. Germain's Q1 2014 Portfolio in Review

As of Q1 2014, D.J. St. Germain held 110 positions worth $653M, down 4.2% from $682M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

D.J. St. Germain withdrew a net $46.4M in Q1 2014, closing 3 positions and reducing 75 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $8.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Energy.

Against the trend, D.J. St. Germain opened a new position in Target worth $3.05M.

  • D.J. St. Germain's largest Q1 2014 buy was Target: 50,470 shares worth $3.05M.
  • D.J. St. Germain added most to Vanguard FTSE Emerging Markets ETF in Q1 2014, an estimated $927K increase.
  • D.J. St. Germain's biggest Q1 2014 reduction was Charles Schwab, cutting an estimated $7.5M.
  • D.J. St. Germain fully exited iShares Biotechnology ETF in Q1 2014, selling an estimated $8.96M.
  • D.J. St. Germain's ten largest holdings make up 33% of its $653M portfolio in Q1 2014.
  • D.J. St. Germain opened 5 new positions and closed 3 in Q1 2014.
  • D.J. St. Germain's portfolio value fell 4.2% quarter-over-quarter to $653M.

Based on D.J. St. Germain's 13F filing for Q1 2014, filed 10 Apr 2014.